XLRN earnings call for the period ending March 31, 2019.
News & Analysis: Acceleron Pharma
SQ earnings call for the period ending December 31, 2018
The promising pharma company ended the year on a sour note, but is still positioned for long-term success.
The market's recent panic may be providing opportunities in this notoriously difficult sector.
Investors have been waiting patiently for some important updates expected at a key medical conference.
You could miss out on market-beating returns if you don't have these top stocks in your portfolio.
These biotech upstarts have deep pockets and late-stage pipelines that could make them savvy buys.
Shares of these biotechs could surge following presentations at an important medical conference.
Sometimes great stocks come in small packages.
Mr. Market thinks the double-digit slide from July was overdone. He may be right.